← Evidence map

ReviewCancer & metabolism2016

Novel drugs that target the metabolic reprogramming in renal cell cancer.

Johannes C van der Mijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27418963